Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS)

Clinical trial NCT02416622 · COMPLETED

Trial details

NCT number: NCT02416622
Sponsor: Beacon Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

X-linked Retinoschisis

Start date: 2015-05-01
Primary completion: 2019-04-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.